CLX financials
The Clorox Company · end-of-day data as of Oct 16, 2026
The Clorox Company
$87.09-7.8%
Hold · 18 analystsPT $98.66 +13.3%
CLX reported revenue of $1.95B for the quarter ended Jun 30, 2026 (Q4 FY2026), down 2.0% from a year earlier. It posted diluted EPS of $1.33, free cash flow of $244M and a net margin of 8.4%.
Valuation
- P/E18.1x
- P/E vs own-0.1%
- P/E vs sector-22.7%
- FCF yield+3.8%
- Market cap$10.53B
Quarterly results
Q4 FY2026: Revenue -2.0% year over year, free cash flow 12.5% of revenue, operating margin 52.5%.
RevenueFree cash flow
| Q4 FY2026 | Jun 30, 2026 | $1.95B | 1.33 | $244M | 41.3% | 52.5% | 8.4% |
| Q3 FY2026 | Mar 31, 2026 | $1.67B | 1.54 | -$165M | 43.2% | 17.0% | 11.2% |
| Q2 FY2026 | Dec 31, 2025 | $1.67B | 1.29 | $269M | 43.2% | 14.1% | 9.4% |
| Q1 FY2026 | Sep 30, 2025 | $1.43B | 0.65 | $57M | 41.7% | 8.4% | 5.6% |
| Q4 FY2025 | Jun 30, 2025 | $1.99B | 2.68 | $219M | 46.5% | 21.1% | 16.7% |
| Q3 FY2025 | Mar 31, 2025 | $1.67B | 1.50 | $233M | 44.6% | 14.3% | 11.2% |
| Q2 FY2025 | Dec 31, 2024 | $1.69B | 1.54 | $127M | 43.8% | 13.7% | 11.4% |
| Q1 FY2025 | Sep 30, 2024 | $1.76B | 0.79 | $182M | 45.8% | 16.3% | 5.6% |
| Q4 FY2024 | Jun 30, 2024 | $1.9B | 1.73 | $259M | 46.5% | 15.1% | 11.4% |
| Q3 FY2024 | Mar 31, 2024 | $1.81B | -0.41 | $127M | 42.2% | 11.6% | -2.8% |
| Q2 FY2024 | Dec 31, 2023 | $1.99B | 0.75 | $101M | 43.5% | 7.4% | 4.7% |
| Q1 FY2024 | Sep 30, 2023 | $1.39B | 0.18 | -$4M | 38.4% | 4.5% | 1.6% |